Select language:

International study proves safety of combination of Sputnik Light and AstraZeneca

 / Главная / Russkiy Mir Foundation / News / International study proves safety of combination of Sputnik Light and AstraZeneca

International study proves safety of combination of Sputnik Light and AstraZeneca


14.02.2022

Photo credit: M. Mishin / Press Service of the Mayor and Government of Moscow / mos.ru (CC BY 4.0)

Scientific studies have proven the safety of the combination of the Russian Sputnik Light vaccine and AstraZeneca, RIA Novosti reports. In a joint statement by the Russian Direct Investment Fund (RDIF), AstraZeneca and R-Pharm, it is noted that this is evidenced by the interim results of the second phase of clinical trials. The trials were held in Armenia and Russia, 100 people from each country took part in it.

The combined use of the two vaccines is reported to have shown an optimal safety and tolerability profile. This is in line with the results of previous vaccine safety trials by AstraZeneca, Sputnik V and Sputnik Light.

Volunteers were followed up for almost two months after the first vaccination. During this time, no serious negative consequences were recorded.

As part of the study, volunteers receive injections of the AstraZeneca vaccine and the Sputnik V component of the vaccine in a different sequence after 28 days.

Russkiy Mir

News by subject

Publications

Marco Maggi: ”Russian to the Bone" 20.01.2024
Italian entrepreneur Marco Maggi's book, "Russian to the Bone," is now accessible for purchase in Italy and is scheduled for release in Russia in the upcoming months. In the book, Marco recounts his personal odyssey, narrating each stage of his life as a foreigner in Russia—starting from the initial fascination to the process of cultural assimilation, venturing into business, fostering authentic friendships, and ultimately, reaching a deep sense of identifying as a Russian at his very core.